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Introduction
Quantification of both myocardial blood flow (MBF) and
myocardial blood volume (MBV) may provide critical
information on coronary artery diseases. We have recently
developed fast mapping techniques for quantifying both
perfusion parameters with the CMR first-pass dynamic
imaging approach and an intravascular contrast agent.
The purpose of this study is to evaluate the techniques in
the assessment of changes in MBF and MBV that occur
with differing severities of coronary artery stenosis during
Dipyridamole or Dobutamine induced hyperemia.
Methods
25 dogs were divided into six groups (Table in Figure 1).
Stenosis was created by using an occluder in the proximal
left anterior descending coronary artery (LAD) in an open-
chest model. First-pass CMR perfusion scans were per-
formed at rest and during the pharmacologically induced
hyperemia for all dogs. Gadomer (Schering AG, Berlin),
an intravascular contrast agent, was injected (0.015
mmol/kg) as a bolus during each perfusion. CMR images
were pre-denoised with a wavelet method [1]. A validated
perfusion quantification method designed in our lab [2]
was applied to obtain MBF (Figure 2) and MBV maps (Fig-
ure 3). The regional data from both LAD perfused anterior
and left circumflex artery (LCX) perfused inferior myocar-
dial beds were determined.
Results
The percentage changes of MBF and MBV before and after
the hyperemia are presented in Table in Figure 1. For the
normal dogs, global MBF and MBV values are given. In
normal dogs, Dipyridamole increases MBF more than
Dobutamine, whereas MBV increases more with Dob-
utamine hyperemia. As expected, in stenotic dogs,
increased MBF values during the hyperemia were propor-
tionally attenuated with the stenosis degrees (negative
correlation) in the LAD region (Figure 4). Interestingly,
the flow reserve in the normal region decreased with sten-
osis severity as well, which agrees with other studies [3-6].
The same finding was observed in MBV during Dob-
utamine hyperemia. However, Dipyridamole vasodila-
tion showed slight increases in blood volume reserve with
increased stenosis severity in both the LAD and LCX
regions (Figure 5). This may reflect adaptive auto-regula-
tion, but further study is needed on this observation.
Conclusion
First-pass perfusion CMR allows for fast evaluation of
MBF/MBV changes during pharmacologically induced
hyperemia. Measurements of both MBF and MBV may
allow for more comprehensive diagnoses of coronary
artery stenosis and better treatment planning.
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Table of dog groups and results. A quantitative CMR perfusion technique was performed in a canine stenosis model during 
Dipyridamole or Dobutamine-induced hyperemia to assess changes in both myocardial blood flow and volume. Hyperemia 
caused different responses in stenotic and normal vessel perfused myocardial regions.Page 2 of 6
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Myocardial blood flow maps from different dogsFigure 2
Myocardial blood flow maps from different dogs. Short axis images showing the left ventricle, right ventricle, and myocardial 
ring with example regions of interest in the LAD bed (white) and LCX bed (yellow).
Journal of Cardiovascular Magnetic Resonance 2008, 10(Suppl 1):A12 http://jcmr-online.com/content/10/S1/A12
Page 4 of 6
(page number not for citation purposes)
Myocardial blood volume maps from different dogsFigure 3
Myocardial blood volume maps from different dogs.
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Myocardial flow reserve during Dipyridamole or Dobutamine for varying stenosis severitiesFigure 4
Myocardial flow reserve during Dipyridamole or Dobutamine for varying stenosis severities.Page 5 of 6
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Myocardial volume reserve during Dipyridamole or Dobutamine for varying stenosis severitiesFigure 5
Myocardial volume reserve during Dipyridamole or Dobutamine for varying stenosis severities.
